Institutional investors hold a majority ownership of MYGN through the 135.48% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended September 2014, these large investors purchased a net $5.8 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CAPITAL RESEARCH & MANAGEMENT CO... Bought 2.4 Million shares of Myriad Genetics Inc
D. E. SHAW & CO. LP Bought 710.4 Thousand shares of Myriad Genetics Inc